A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin

NCT01218204 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

287

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidaemias
Dyslipidemias

Interventions

DRUG: 10mg atorvastatin
DRUG: 80mg atorvastatin
DRUG: GSK1292263 Placebo
DRUG: 100mg GSK1292263
DRUG: 300mg GSK1292263
DRUG: 800mg GSK1292263
DRUG: 10mg ezetimibe
OTHER: Washout

Sponsor

GlaxoSmithKline